ROYAL BANK OF CANADA - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,000
-33.3%
2,358
-59.7%
0.00%
Q4 2022$6,000
+500.0%
5,852
+1040.7%
0.00%
Q3 2022$1,0000.0%513
+116.5%
0.00%
Q2 2022$1,000
-93.8%
237
-89.8%
0.00%
Q1 2022$16,000
-72.4%
2,325
-66.1%
0.00%
Q4 2021$58,000
+70.6%
6,865
+51.4%
0.00%
Q3 2021$34,000
+100.0%
4,533
+77.2%
0.00%
Q2 2021$17,000
-26.1%
2,558
+12.0%
0.00%
Q1 2021$23,000
+228.6%
2,283
+133.2%
0.00%
Q4 2020$7,000
+250.0%
979
+226.3%
0.00%
Q3 2020$2,0000.0%3000.0%0.00%
Q2 2020$2,000
-80.0%
300
-86.0%
0.00%
Q1 2020$10,000
-16.7%
2,149
+59.9%
0.00%
Q4 2019$12,000
+1100.0%
1,344
+348.0%
0.00%
Q3 2019$1,0000.0%3000.0%0.00%
Q2 2019$1,000
-50.0%
3000.0%0.00%
Q1 2019$2,000
+100.0%
3000.0%0.00%
Q4 2018$1,000
-75.0%
300
-51.3%
0.00%
Q3 2018$4,000
-33.3%
616
-25.0%
0.00%
Q2 2018$6,000
-85.0%
821
-54.4%
0.00%
Q1 2018$40,000
+700.0%
1,800
+418.7%
0.00%
Q4 2017$5,000
-76.2%
347
-74.0%
0.00%
Q3 2017$21,000
+2000.0%
1,337
+1571.2%
0.00%
Q2 2017$1,000
-88.9%
80
-80.0%
0.00%
Q1 2017$9,0004000.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TRV GP II, LLC 2,697,829$20,045,00088.84%
TRV GP III, LLC 3,048,780$22,652,0004.30%
Logos Global Management LP 2,000,000$14,860,0001.07%
SILVERARC CAPITAL MANAGEMENT, LLC 208,559$1,550,0000.88%
PFM Health Sciences, LP 3,848,822$28,597,0000.84%
Yorktown Management & Research Co Inc 113,200$841,0000.63%
Moloney Securities Asset Management, LLC 282,250$2,097,0000.38%
PATHWAY CAPITAL MANAGEMENT, LP 84,763$630,0000.30%
Sofinnova Investments, Inc. 637,347$4,735,0000.28%
Omega Fund Management, LLC 275,513$2,047,0000.23%
View complete list of JOUNCE THERAPEUTICS INC shareholders